Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Many videos on the social media platform TikTok that are focused on obsessive thoughts about food include patient ...

The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

A research team at Mount Sinai have developed a risk score they found accurate in predicting Crohn’s disease in patients ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

In the near term, commercial efforts might raise the chances that new patients are prescribed Novo Nordisk’s drug, assuming ...

Michela Tindera Botox, the anti-wrinkle drug that’s been injected into countless celebrity foreheads. Today, it’s made by a major American pharmaceutical company. And Westport’s just one of many Irish ...

A new drug to treat the early stages of Alzheimer’s disease has been approved for use in Australia from today.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.